BioWorld Science

Oct. 15, 2019

View Archived Issues

ALKBH proteins are potential therapeutic targets in HNSCC

Read More

Novel GET zebrafish larvae model of invasive mycoses

Read More

GalNAc-siTAZ improves hepatic inflammation, fibrosis and liver damage in models of NASH

Read More

Targeting Piezo1 channel as promising new therapeutic strategy in prostate cancer

Read More

Reservoir grows when ART starts

Read More

Accidental immunity gives rotavirus insight

Read More

Ironing out regional differences affects anxiety

Read More

Patient enrollment under way in phase I study of FT-516

Read More

Matinas BioPharma initiates EnACT study of MAT-2203 for fungal cryptococcal meningitis

Read More

Wuhan Institute of Virology describes respiratory syncytial virus vaccine antigen

Read More

Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented

Read More

Recombinant Clonorchis sinensis heat shock cognate protein B patented by Xuzhou Medical University

Read More

Bristol-Myers Squibb identifies new TYK2 inhibitors

Read More

Intra-Cellular Therapies discovers 5-HT2A antagonists/mu-opioid receptor partial agonists

Read More

DE Shaw Research and Relay Therapeutics disclose PTPN11 inhibitors

Read More

Progression-free survival improved with ivosidenib in pivotal cholangiocarcinoma trial

Read More

NMSS grant supports Clene's development of nanocatalytic therapeutic CNM-Au8 for MS

Read More

Immunotherapy frontiers: 'Strength in numbers', 'it only takes one' both true for neoantigens

Read More

Primary endpoint met in registrational MOXIe trial of omaveloxolone for Friedreich's ataxia

Read More

Collaborative Medicinal Development enrolls first patient in new study of CuATSM for ALS

Read More

Viela Bio enrolling kidney transplant recipients for phase IIa trial of VIB-4920 and belatacept

Read More

AstraZeneca initiates first-in-human study of AZD-4041 in healthy volunteers

Read More